Suppliers / Shandong Lixin Pharmaceutical

Shandong Lixin Pharmaceutical

China Updated 9 July 2026

Shandong Lixin Pharmaceutical is an API manufacturer based in China. It holds 2 active US drug master files across a filed portfolio of 2 molecules.

2
active US DMFs
0
valid CEPs
1
registered plants 1 with an FDA FEI number
0
filings across 0 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
1 of 1 confirmed
Sources: FDA Establishment Registration, read 4 May 2026.

Registered plants

Site FDA FEI
China, China 3017297099

What they file, and where

Molecule Regulators Docs
Molnupiravir US FDA 1
Nilotinib US FDA 1

Also appears on these molecule pages

Molnupiravir API Nilotinib API

Questions about Shandong Lixin Pharmaceutical

Does Shandong Lixin Pharmaceutical hold a US DMF or a CEP?
Shandong Lixin Pharmaceutical holds 2 active US drug master files. A drug master file is a submission to the FDA describing how an ingredient is made; a CEP is the EDQM's certificate that the substance meets its European Pharmacopoeia monograph. Both are filings rather than approvals.
Is Shandong Lixin Pharmaceutical FDA-registered?
One site operated by Shandong Lixin Pharmaceutical carries an FDA establishment identifier (FEI), which means it is registered with the FDA as a drug establishment. Registration is not the same as approval or inspection clearance.
Where does Shandong Lixin Pharmaceutical manufacture?
1 registered site is on record, in China (China). Every site is listed on this page with the register it came from.
What does Shandong Lixin Pharmaceutical make?
2 molecules are on record against Shandong Lixin Pharmaceutical, including Molnupiravir and Nilotinib. Each links through to that molecule's full manufacturer list.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Shandong Lixin Pharmaceutical comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Comparable suppliers

MSN Laboratories shares 2 molecules Hetero shares 1 molecule Cipla shares 1 molecule Dr Reddy's Laboratories shares 1 molecule Granules India shares 1 molecule

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability